Daniel W. Lin

28.6k total citations · 6 hit papers
273 papers, 16.9k citations indexed

About

Daniel W. Lin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Daniel W. Lin has authored 273 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Pulmonary and Respiratory Medicine, 62 papers in Surgery and 56 papers in Molecular Biology. Recurrent topics in Daniel W. Lin's work include Prostate Cancer Treatment and Research (164 papers), Prostate Cancer Diagnosis and Treatment (128 papers) and Bladder and Urothelial Cancer Treatments (38 papers). Daniel W. Lin is often cited by papers focused on Prostate Cancer Treatment and Research (164 papers), Prostate Cancer Diagnosis and Treatment (128 papers) and Bladder and Urothelial Cancer Treatments (38 papers). Daniel W. Lin collaborates with scholars based in United States, Canada and South Africa. Daniel W. Lin's co-authors include Peter S. Nelson, Robert L. Vessella, Beatrice S. Knudsen, Brian R. Fritz, Stacia K. Wyman, Muneesh Tewari, Rachael K. Parkin, Robert Gentleman, Jennifer Noteboom and Evan M. Kroh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Daniel W. Lin

259 papers receiving 16.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating microRNAs as stable blood-based markers for cancer detection

2008 6.5k citations Patrick S. Mitchell, Rachael K. Parkin et al. Proceedings of the National Academy of Sciences profile →
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

2007 633 citations Daniel W. Lin et al. Journal of Clinical Oncology profile →
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

2018 410 citations Daniel W. Lin et al. profile →
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

2022 226 citations Daniel W. Lin et al. profile →
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

2023 172 citations John T. Wei, Ian M. Thompson et al. profile →
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

2022 124 citations Daniel W. Lin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel W. Lin	7.7k	7.1k	7.1k	2.3k	2.0k	273	16.9k
Lawrence D. True	6.1k 0.8×	8.0k 1.1×	3.3k 0.5×	2.0k 0.9×	3.5k 1.8×	277	15.9k
Kurt Miller	4.6k 0.6×	9.1k 1.3×	3.5k 0.5×	2.1k 0.9×	2.9k 1.5×	358	14.7k
Anders Bjartell	4.3k 0.6×	7.3k 1.0×	3.0k 0.4×	1.5k 0.6×	2.5k 1.3×	345	13.5k
Malcolm D. Mason	6.5k 0.8×	7.5k 1.1×	4.0k 0.6×	3.2k 1.4×	3.7k 1.9×	241	18.0k
Leonard G. Gomella	3.4k 0.4×	6.7k 0.9×	2.5k 0.4×	2.6k 1.2×	2.5k 1.3×	385	12.7k
Lori J. Sokoll	3.8k 0.5×	4.6k 0.6×	3.3k 0.5×	1.8k 0.8×	2.3k 1.2×	231	12.4k
Axel S. Merseburger	5.9k 0.8×	9.6k 1.3×	2.6k 0.4×	4.1k 1.8×	2.5k 1.3×	421	14.3k
Mitchell C. Benson	3.9k 0.5×	8.6k 1.2×	2.2k 0.3×	3.1k 1.4×	2.8k 1.4×	268	13.3k
Felix Y. Feng	7.4k 1.0×	7.3k 1.0×	6.2k 0.9×	1.9k 0.8×	3.3k 1.7×	444	16.2k
Hideaki Miyake	4.0k 0.5×	4.7k 0.7×	2.1k 0.3×	2.7k 1.2×	3.2k 1.6×	620	10.8k

Countries citing papers authored by Daniel W. Lin

Since Specialization

Citations

This map shows the geographic impact of Daniel W. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Lin more than expected).

Fields of papers citing papers by Daniel W. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Lin. The network helps show where Daniel W. Lin may publish in the future.

Co-authorship network of co-authors of Daniel W. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Lin. A scholar is included among the top collaborators of Daniel W. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Lin. Daniel W. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Siwei, Mehrdad Mokhtari, Ribwar Ahmadi, et al.. (2025). Closed-loop, machine learning–driven optimization of reactor yields in reactive carbon electrolyzers. ChemRxiv.

Ji, Tengxiao, Yang Cao, Daniel W. Lin, Monika Stolar, & Curtis P. Berlinguette. (2024). Molecular Interlayer with Large Cations Supports Efficient, Stable Perovskite Solar Cells. ACS Applied Energy Materials. 7(13). 5371–5378. 3 indexed citations

Cheng, Heather H., Daniel J. Lee, Michael A. Liss, et al.. (2024). Prostate screening for men with inherited risk of developing aggressive prostate cancer: The PATROL study.. Journal of Clinical Oncology. 42(4_suppl). TPS357–TPS357.

Cheng, Heather H., Daniel W. Lin, Evan Y. Yu, et al.. (2024). SWOG S2210: A phase II study of neoadjuvant carboplatin for localized, high-risk prostate cancer with germline BRCA1/2 mutations.. Journal of Clinical Oncology. 42(4_suppl). TPS354–TPS354.

Labrecque, Mark P., Lisha G. Brown, Ilsa M. Coleman, et al.. (2023). Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer. The Prostate. 84(1). 100–110. 4 indexed citations

Zhang, Ailin, Lisha G. Brown, Ilsa M. Coleman, et al.. (2023). Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers. Cancer Research Communications. 3(11). 2358–2374. 9 indexed citations

MacLeod, Benjamin P., Mehrdad Mokhtari, Kevan E. Dettelbach, et al.. (2023). A self-driving laboratory optimizes a scalable process for making functional coatings. Cell Reports Physical Science. 4(5). 101411–101411. 10 indexed citations

Zhou, Zhicheng, Deyong Jia, Shan Li, et al.. (2023). Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth. Oncogene. 42(32). 2428–2438. 5 indexed citations

Labrecque, Mark P., Lisha G. Brown, Ilsa M. Coleman, et al.. (2021). RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer. Cancer Research. 81(18). 4736–4750. 23 indexed citations

10.

Zhu, Kehao, Yingye Zheng, Lisa F. Newcomb, et al.. (2021). Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. Cancer. 128(2). 269–274. 5 indexed citations

11.

Madan, Ravi A., Emmanuel S. Antonarakis, Charles G. Drake, et al.. (2020). Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T. JNCI Journal of the National Cancer Institute. 112(6). 562–573. 51 indexed citations

12.

McKay, Rana R., Huihui Ye, Wanling Xie, et al.. (2019). Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. Journal of Clinical Oncology. 37(11). 923–931. 76 indexed citations

13.

Zhao, Shanshan, Milan S. Geybels, Amy Leonardson, et al.. (2016). Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. Clinical Cancer Research. 23(1). 311–319. 57 indexed citations

14.

Lin, Daniel W., Lisa F. Newcomb, Elissa C. Brown, et al.. (2013). Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study. Clinical Cancer Research. 19(9). 2442–2450. 111 indexed citations

15.

Wright, Jonathan L., Erika M. Kwon, Elaine A. Ostrander, et al.. (2011). Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes. Cancer Epidemiology Biomarkers & Prevention. 20(4). 619–627. 120 indexed citations

16.

Lin, Daniel W., Liesel M. FitzGerald, Rong Fu, et al.. (2011). Genetic Variants in the LEPR , CRY1 , RNASEL , IL4 , and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality. Cancer Epidemiology Biomarkers & Prevention. 20(9). 1928–1936. 55 indexed citations

17.

Risk, Michael, Beatrice S. Knudsen, Ilsa M. Coleman, et al.. (2010). Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect. Clinical Cancer Research. 16(22). 5414–5423. 43 indexed citations

18.

Mitchell, Patrick S., Rachael K. Parkin, Evan M. Kroh, et al.. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences. 105(30). 10513–10518. 6512 indexed citations breakdown →

19.

Mostaghel, Elahe A., Stephanie T. Page, Daniel W. Lin, et al.. (2007). Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer. Cancer Research. 67(10). 5033–5041. 388 indexed citations

20.

Lin, Daniel W., Ilona N. Holcomb, Edward W. Arfman, et al.. (2005). Detection, isolation, and initial characterization of disseminated tumor cells following enrichment in patients with prostate cancer.. Cancer Research. 65. 97–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact